Dr. Ted Mikuls, MD
Not yet claimedRheumatologist · Physician (MD)
Omaha, NE
Ted Mikuls is a rheumatology physician and professor at the University of Nebraska Medical Center in Omaha. He helped write the American College of Rheumatology's 2020 guideline on treating gout.
About Dr. Ted Mikuls, MD
Updated Sep 21, 2026 · next review Dec 20, 2026Dr. Ted Mikuls is a rheumatologist and professor at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
He was involved in creating the American College of Rheumatology's 2020 guideline for treating gout.
He has an academic and research profile that can be found on Google Scholar and ResearchGate, which list his published research work.
Between 2021 and 2025, he received a total of $15,249.49 in payments from drug and medical companies, according to the CMS Open Payments database. This kind of industry payment is common and legal for doctors involved in research and education.
- Professor at UNMC
- Dr. Mikuls works as a physician and professor of rheumatology at the University of Nebraska Medical Center in Omaha, NE. unmc.edu
- ACR gout guideline contributor
- He contributed to the American College of Rheumatology's 2020 guideline on treating gout. unmc.edu
- Published research record
- His publication history is indexed on Google Scholar. scholar.google.com
- Research profile on ResearchGate
- He maintains a research profile on ResearchGate listing his academic work. researchgate.net
Worth knowing
- From 2021 to 2025, Dr. Mikuls received a total of $15,249.49 in payments from pharmaceutical companies, including Horizon Therapeutics, Merck, UCB, Pfizer, and Janssen, according to the CMS Open Payments database. Such payments are common and legal for physicians involved in research or education. openpaymentsdata.cms.gov
Industry payments (CMS Open Payments)
Open the CMS recordFederal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.
2021 to 2025
$15,249
11 payments
| 2021 | $8,040 |
| 2022 | $0 |
| 2023 | $55 |
| 2024 | $0 |
| 2025 | $7,155 |
Top payers
- Horizon Therapeutics plc$5,077
- Merck Sharp & Dohme LLC$3,605
- UCB SA$3,550
- PFIZER INC.$2,963
- Janssen Biotech, Inc.$55
Payment types
- Consulting Fee$10,160
- Honoraria$5,035
- Education$55
A word of caution about these numbers
A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.
As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.
Sources: unmc.edu · linkedin.com · scholar.google.com · researchgate.net · openpaymentsdata.cms.gov. Something wrong or out of date? Tell us and we will correct it.
Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.
Practice location
UNMC Division of Rheumatology and Immunology
988102 Nebraska Medical Ctr
Omaha, NE 68198
Open in maps